AstraZeneca abandonne la construction d'une usine de vaccins de 450 millions de livres à Liverpool après une réduction du financement travailliste.

AstraZeneca has scrapped its plans for a £450 million vaccine manufacturing plant in Liverpool, citing reduced government funding, according to the pharmaceutical company. The investment was first hailed as a 'vote of confidence' in Liverpool and the UK's life science sector. However, Labour ministers ended up providing a smaller funding amount than initially expected. An AstraZeneca spokesperson explained that Several factors, including the timing and decrease in the final offer compared to the previous government's proposal, influenced the decision. The government mentioned that a 'shift in the investment structure' prompted a decrease in the grant offer, emphasizing the importance of value to taxpayers.